Pulmonary Embolism Imaging: CT Pulmonary Angiography, Westermark Sign, and AI Diagnosis

 


Introduction

A Single Chest X-ray Sign That Can Save a Life

Every emergency department faces the same unforgiving challenge: a patient arrives with sudden shortness of breath, low oxygen saturation, and vague chest discomfort. Some patients appear remarkably stable, while others deteriorate within minutes. Among these presentations, pulmonary embolism (PE) remains one of the most dangerous diagnoses because its symptoms frequently mimic far more common cardiopulmonary disorders.

For radiologists, emergency physicians, and intensivists, the ability to recognize subtle imaging clues often determines whether treatment begins in time to prevent catastrophic right ventricular failure or sudden death.

One such clue is the Westermark sign—a classic yet surprisingly uncommon radiographic finding that reflects regional pulmonary oligemia caused by acute arterial obstruction. Although modern medicine increasingly relies on multidetector CT pulmonary angiography (CTPA) for definitive diagnosis, conventional chest radiography continues to serve as the first imaging examination performed in many emergency departments worldwide.

The paradox is striking: while chest radiography has relatively low sensitivity for pulmonary embolism, it occasionally reveals highly specific signs that immediately raise clinical suspicion. Among these, the Westermark sign occupies a unique place in radiologic history. Recognizing it can dramatically shorten the diagnostic pathway and expedite life-saving anticoagulation or reperfusion therapy.

The case presented in this article illustrates precisely that scenario. A 48-year-old woman presented with acute dyspnea and hypoxemia. Her history included estrogen therapy, previous deep vein thrombosis requiring anticoagulation, and a family history of fatal pulmonary embolism. Laboratory testing demonstrated markedly elevated D-dimer levels, electrocardiography showed right heart strain, and the initial chest radiograph revealed the classic Westermark sign. Subsequent CT pulmonary angiography confirmed extensive thromboembolic occlusion of the right pulmonary artery and additional emboli within branches of the left pulmonary artery. Following anticoagulation therapy, the patient recovered successfully.

This seemingly straightforward case highlights a broader evolution occurring throughout modern radiology. Imaging is no longer interpreted solely by human observers. Artificial intelligence systems now assist radiologists by automatically identifying pulmonary emboli on CT examinations, quantifying clot burden, estimating right ventricular strain, prioritizing urgent cases, and integrating clinical data into comprehensive decision-support platforms.

The convergence of advanced imaging technology and AI has transformed pulmonary embolism diagnosis from a purely anatomical assessment into an intelligent, workflow-driven process. Deep learning algorithms trained on millions of imaging studies can detect emboli with remarkable sensitivity, while foundation models promise to integrate imaging findings with electronic health records, laboratory results, and clinical history to provide personalized diagnostic recommendations.

Consequently, understanding pulmonary embolism today requires more than recognizing filling defects on CT scans. Clinicians must appreciate the interplay between traditional radiographic signs, multidetector CT technology, machine learning, enterprise imaging infrastructure, and emerging generative AI systems that collectively define the future of emergency medicine.

This comprehensive review explores the radiologic features of pulmonary embolism through the lens of a real clinical case, emphasizing the diagnostic importance of the Westermark sign, modern CT pulmonary angiography techniques, differential diagnosis, AI-assisted interpretation, and future developments that are reshaping emergency thoracic imaging. Throughout the discussion, we will integrate evidence-based imaging principles with practical clinical insights aimed at radiologists, emergency physicians, medical students, imaging scientists, and healthcare executives seeking to understand how precision imaging continues to improve outcomes for patients with one of medicine's most time-critical emergencies.

Clinical Background

Pulmonary Embolism: One of the Most Time-Critical Diagnoses in Emergency Radiology

Among all cardiovascular emergencies, pulmonary embolism (PE) remains one of the most challenging conditions to diagnose because its clinical presentation ranges from completely asymptomatic to sudden cardiovascular collapse. Every year, hundreds of thousands of patients worldwide develop acute pulmonary embolism, making it one of the leading causes of preventable in-hospital mortality.

For radiologists, PE represents a disease in which imaging often determines survival. Unlike many other thoracic disorders, delayed diagnosis can rapidly lead to right ventricular failure, obstructive shock, and death. Conversely, timely recognition allows prompt anticoagulation or reperfusion therapy, dramatically improving patient outcomes.

The presented case exemplifies this clinical urgency. A 48-year-old woman arrived at the emergency department with acute dyspnea and hypoxemia. Her medical history included several major thromboembolic risk factors, including estrogen therapy, previous deep vein thrombosis requiring anticoagulation, and a family history of fatal pulmonary embolism. Initial laboratory evaluation demonstrated a markedly elevated D-dimer concentration of 2,073 ng/mL, while electrocardiography showed right bundle branch block and right axis deviation, findings suggestive of acute right heart strain. Chest radiography demonstrated the classic Westermark sign, prompting CT pulmonary angiography, which confirmed extensive pulmonary arterial thromboembolism. The patient improved following anticoagulation with warfarin.

This clinical scenario illustrates the importance of integrating patient history, laboratory biomarkers, electrocardiography, and multimodality imaging rather than relying on any single diagnostic test.


Epidemiology

Pulmonary embolism is the third most common acute cardiovascular disease after myocardial infarction and stroke.

Recent epidemiological studies estimate:

  • More than 900,000 cases annually in the United States
  • Approximately 100,000–300,000 deaths each year
  • Nearly one-third of untreated massive PE patients die within the first few hours
  • Early diagnosis reduces mortality from approximately 30% to below 5%

These statistics underscore why pulmonary embolism remains a major focus of emergency medicine, radiology, cardiology, and critical care.

The widespread adoption of multidetector CT pulmonary angiography has substantially increased the detection of both clinically significant emboli and smaller subsegmental thrombi, reshaping contemporary management strategies.


Virchow's Triad: The Foundation of Pulmonary Embolism

Understanding pulmonary embolism begins with Virchow's Triad, which describes the three principal mechanisms responsible for venous thrombosis.

1. Venous Stasis

Blood flow slows within the deep veins, promoting clot formation.

Common causes include:

  • prolonged bed rest
  • recent surgery
  • long-distance travel
  • paralysis
  • heart failure
  • obesity

2. Endothelial Injury

Damage to the vascular endothelium activates coagulation pathways.

Examples include:

  • orthopedic trauma
  • vascular surgery
  • central venous catheters
  • inflammatory vascular disease

3. Hypercoagulability

Numerous inherited and acquired conditions predispose patients to excessive clot formation.

Examples include:

  • malignancy
  • pregnancy
  • postpartum state
  • oral contraceptives
  • estrogen replacement therapy
  • inherited thrombophilia
  • antiphospholipid syndrome

The patient described in this case possessed multiple elements of Virchow's triad, particularly estrogen therapy and a history of deep venous thrombosis, substantially increasing her risk of recurrent thromboembolic disease.


Pathophysiology

From Leg Vein to Pulmonary Artery

Approximately 90% of pulmonary emboli originate from thrombi within the deep veins of the lower extremities.

The sequence typically follows:


The embolus abruptly interrupts pulmonary arterial blood flow, initiating a cascade of hemodynamic and respiratory consequences.


Hemodynamic Consequences

Occlusion of pulmonary arteries immediately increases pulmonary vascular resistance.

This leads to:

  • increased right ventricular afterload
  • acute right ventricular dilation
  • tricuspid regurgitation
  • interventricular septal bowing
  • reduced left ventricular filling
  • decreased cardiac output
  • systemic hypotension
  • obstructive shock

Massive emboli may obstruct more than 50% of the pulmonary arterial circulation, rapidly producing circulatory collapse.


Respiratory Consequences

The pulmonary embolus also disrupts normal gas exchange.

Affected lung segments remain ventilated but receive little or no perfusion.

This creates:

  • ventilation-perfusion mismatch
  • increased physiologic dead space
  • hypoxemia
  • hyperventilation
  • respiratory alkalosis

In severe cases, pulmonary infarction may occur, producing pleuritic chest pain and hemoptysis.


Why Does the Westermark Sign Occur?

The Westermark sign represents one of the earliest radiographic manifestations of pulmonary embolism.


Rather than demonstrating the thrombus itself, the chest radiograph depicts the physiological consequence of diminished pulmonary perfusion.

Consequently, the Westermark sign is considered an indirect radiographic sign of pulmonary embolism rather than direct visualization of the embolus.


Why Is It Rare?

Despite its classic status, the Westermark sign is encountered infrequently.

Several reasons explain this:

  • Chest radiography has relatively low sensitivity.
  • Many emboli are too small to significantly alter pulmonary perfusion.
  • Superimposed lung disease may obscure vascular changes.
  • Interpretation depends heavily on the reader's experience.
  • Modern diagnostic pathways frequently proceed directly to CT pulmonary angiography before classic radiographic findings become apparent.

Nevertheless, when identified correctly, the Westermark sign substantially increases clinical suspicion for pulmonary embolism and should immediately prompt definitive vascular imaging.


Risk Factors Demonstrated by This Patient

The current case contains several textbook risk factors that every radiologist should actively recognize before interpreting imaging studies.

Previous Deep Vein Thrombosis

Prior venous thromboembolism is among the strongest predictors of recurrent pulmonary embolism.


Estrogen Therapy

Exogenous estrogen increases coagulation factor synthesis while reducing natural anticoagulant activity, significantly increasing thromboembolic risk.


Family History

Inherited thrombophilic disorders frequently present through familial clustering of venous thromboembolism.


Elevated D-dimer

Although nonspecific, markedly elevated D-dimer concentrations support active thrombus formation and degradation when interpreted within the appropriate clinical context.


Clinical Presentation

The symptoms of pulmonary embolism are notoriously variable.

Common manifestations include:

  • sudden dyspnea
  • pleuritic chest pain
  • tachycardia
  • hypoxemia
  • syncope
  • hemoptysis
  • cyanosis
  • unexplained anxiety

The current patient exhibited acute dyspnea and hypoxemia, two of the most frequent presenting symptoms of acute pulmonary embolism.

Importantly, symptom severity correlates poorly with clot burden. Some patients harbor extensive bilateral emboli with relatively mild symptoms, whereas others develop profound hemodynamic instability from centrally located thrombi.


Why Imaging Determines Prognosis

Unlike many diseases where imaging primarily confirms an established diagnosis, pulmonary embolism imaging directly influences immediate therapeutic decisions.

Radiologic findings determine:

  • Whether anticoagulation should begin immediately.
  • Whether systemic thrombolysis is indicated.
  • Whether catheter-directed thrombectomy is necessary.
  • Whether intensive care admission is required.
  • Whether chronic thromboembolic pulmonary hypertension should be monitored during follow-up.

Accordingly, modern radiologists are expected not only to identify emboli but also to assess clot burden, right ventricular strain, pulmonary infarction, and alternative thoracic diagnoses that may mimic pulmonary embolism.

The evolution from conventional chest radiography to multidetector CT pulmonary angiography—and now to AI-assisted image interpretation—has transformed pulmonary embolism from a frequently missed diagnosis into one of the most accurately detected vascular emergencies in contemporary medical imaging.


Clinical Pearls

  • Pulmonary embolism remains one of the leading causes of preventable hospital death.
  • Most emboli originate from lower-extremity deep vein thrombosis.
  • The Westermark sign reflects regional pulmonary oligemia distal to an occluded pulmonary artery.
  • Chest radiography alone cannot exclude pulmonary embolism.
  • CT pulmonary angiography is the imaging reference standard for diagnosis.
  • Clinical history and imaging findings must always be interpreted together.
  • Early recognition markedly reduces mortality and improves outcomes.

Imaging Findings

Medical imaging remains the cornerstone of pulmonary embolism (PE) diagnosis. Although laboratory biomarkers such as D-dimer and clinical prediction models (e.g., Wells Score, Geneva Score) help estimate pretest probability, definitive diagnosis relies on imaging.

The current case is particularly instructive because it demonstrates a classic but uncommon sequence:

Chest X-ray → Recognition of the Westermark Sign → CT Pulmonary Angiography (CTPA) → Confirmation of Acute Pulmonary Embolism

This imaging pathway illustrates how conventional radiography can still provide a life-saving clue, even in the era of advanced multidetector CT and AI-assisted diagnosis.


Imaging Workflow in This Case


This sequence highlights the enduring value of conventional radiography as the first imaging examination in emergency thoracic imaging.


Figure 1. Chest Posteroanterior View

Chest radiograph demonstrating the classic Westermark sign characterized by focal oligemia of the right mid-lung resulting from acute obstruction of the right upper pulmonary arterial circulation.


Radiologist Interpretation

Systematic interpretation reveals several important observations.

Cardiomediastinal Silhouette

  • Cardiac size is within normal limits.
  • No evidence of cardiomegaly.
  • Mediastinal contours remain preserved.

Lung Fields

The most striking abnormality is a localized area of increased radiolucency involving the right mid-lung.

This finding reflects:

  • decreased pulmonary vascular markings
  • focal pulmonary oligemia
  • abrupt reduction in distal pulmonary perfusion

Unlike diffuse hyperinflation, the hyperlucency is confined to a vascular territory supplied by the obstructed pulmonary artery.


Pulmonary Vasculature

The right upper pulmonary artery appears abruptly attenuated.

Distal vascular arborization is markedly reduced.

This reduction in vascular caliber represents the hallmark of the Westermark sign.


Pleural Space

  • No pleural effusion
  • No pneumothorax

Osseous Structures

No acute osseous abnormality is identified on the frontal projection.


What Exactly Is the Westermark Sign?

The Westermark sign represents regional pulmonary oligemia secondary to acute pulmonary arterial obstruction.

Unlike many chest radiographic findings that reflect increased opacity, the Westermark sign is characterized by increased radiolucency.

The sequence is straightforward:


Importantly, the sign reflects physiology rather than direct visualization of thrombus.


Why Does the Lung Look Darker?

Many physicians initially assume that pulmonary embolism should produce increased opacity.

The opposite occurs.

Because blood volume within the affected vascular bed falls dramatically:

  • fewer vessels are visible
  • vessel caliber decreases
  • lung density decreases
  • radiographic lucency increases

The resulting appearance is a relatively "empty" vascular territory.


Differential Diagnosis of Regional Hyperlucency

Several conditions may mimic the Westermark sign.

Radiologists should distinguish pulmonary embolism from:

1. Swyer–James Syndrome

  • unilateral hyperlucent lung
  • postinfectious bronchiolitis
  • chronic appearance
  • decreased vascularity

2. Giant Pulmonary Bulla

Large emphysematous bullae produce localized hyperlucency but demonstrate thin walls and surrounding emphysema.


3. Pneumothorax

Absence of peripheral lung markings beyond the visceral pleural line differentiates pneumothorax.


4. Severe Emphysema

Diffuse hyperinflation rather than segmental vascular loss.


5. Technical Overexposure

Image acquisition artifacts should always be excluded before diagnosing focal oligemia.


Other Chest X-ray Signs of Pulmonary Embolism

Although the Westermark sign is perhaps the most famous radiographic sign, several additional findings may coexist.

Hampton Hump: Peripheral wedge-shaped pulmonary opacity indicates pulmonary infarction.


Fleischner Sign: Enlargement of the central pulmonary artery due to thrombus.


Elevated Hemidiaphragm: Reflecting regional volume loss.


Small Pleural Effusion: Common but nonspecific.


Plate-like Atelectasis: Frequently accompanies pulmonary embolism.

The current patient primarily demonstrated the Westermark sign without obvious pulmonary infarction, emphasizing that chest radiographic manifestations vary depending on clot burden and timing.


Figure 2. CTA Coronal

Coronal CT pulmonary angiography demonstrates extensive thromboembolic occlusion involving the right pulmonary artery and additional emboli within multiple branches of the left pulmonary artery.


CT Interpretation

CT pulmonary angiography immediately confirms the diagnosis suspected on chest radiography.


Main Pulmonary Artery

No saddle embolus is identified.


Right Pulmonary Artery

A large intraluminal filling defect occupies the right pulmonary artery.

The thrombus demonstrates:

  • central low attenuation
  • complete contrast interruption
  • acute vessel occlusion

This finding explains the regional oligemia observed on the chest radiograph.


Right Upper Lobe Pulmonary Artery

Occlusive thrombus extends into upper lobe branches.

Complete obstruction produces severe reduction in pulmonary perfusion.


Right Middle Lobe Artery

Additional occlusive emboli are present.


Left Pulmonary Artery

Multiple filling defects are identified within segmental branches.

Therefore, this represents bilateral pulmonary embolism despite the more prominent right-sided findings.


CT Diagnostic Features

Typical CT findings include:

✓ Intraluminal filling defect

✓ Contrast surrounding thrombus

✓ Vessel enlargement

✓ Abrupt vascular cutoff

✓ Distal non-opacification

These findings remain the gold standard for imaging diagnosis.


Right Ventricular Assessment

Whenever pulmonary embolism is diagnosed, radiologists should evaluate:

  • RV/LV diameter ratio
  • interventricular septal bowing
  • reflux of contrast into the inferior vena cava
  • reflux into hepatic veins

These findings predict mortality better than clot burden alone.

Although not specifically described in this case, structured reporting should routinely include right-heart strain assessment.


Why CTPA Is the Gold Standard

Modern multidetector CT offers several advantages:

  • sensitivity exceeding 90% for clinically significant PE
  • rapid acquisition in seconds
  • whole-thorax evaluation
  • identification of alternative diagnoses
  • assessment of right ventricular dysfunction
  • suitability for AI-assisted triage

This explains why CTPA has largely replaced ventilation–perfusion scintigraphy as the primary imaging modality in most emergency departments.


AI-Assisted Image Interpretation

Contemporary AI systems can automatically analyze CTPA studies immediately after image reconstruction.

Typical capabilities include:

  • pulmonary artery segmentation
  • embolus detection
  • clot volume quantification
  • embolus localization
  • RV/LV ratio calculation
  • structured report generation
  • emergency worklist prioritization

Instead of replacing radiologists, AI functions as an intelligent second reader, reducing perceptual errors and shortening time to diagnosis.


Imaging Pearls from This Case

  1. A normal chest X-ray does not exclude pulmonary embolism.
  2. The Westermark sign is uncommon but highly suggestive when present.
  3. Regional hyperlucency reflects pulmonary oligemia rather than emphysema.
  4. CTPA is essential for definitive diagnosis.
  5. Bilateral emboli may produce asymmetric radiographic findings.
  6. Clot burden should be assessed together with right ventricular strain.
  7. Structured reporting improves communication with emergency physicians.
  8. AI-assisted CTPA analysis can accelerate diagnosis in high-volume emergency settings.
  9. Clinical history is indispensable when interpreting subtle imaging findings.
  10. Early recognition of indirect radiographic signs can significantly improve patient outcomes.

In this patient, the subtle yet classic Westermark sign on the initial chest radiograph served as the pivotal clue that prompted urgent CT pulmonary angiography, leading to the diagnosis of extensive bilateral pulmonary embolism and timely anticoagulation therapy. This case reinforces a fundamental lesson in emergency radiology: even in the era of advanced CT and artificial intelligence, meticulous interpretation of a seemingly routine chest X-ray can still be lifesaving.

Artificial Intelligence Is Transforming Pulmonary Embolism Diagnosis

Pulmonary embolism (PE) has traditionally been considered one of the most difficult emergency diagnoses in radiology. Its imaging manifestations range from subtle peripheral emboli to massive saddle embolisms, while its clinical symptoms often overlap with pneumonia, myocardial infarction, heart failure, pneumothorax, and chronic obstructive pulmonary disease.

As CT utilization has expanded worldwide, radiologists are interpreting an unprecedented number of chest CT examinations each day. High-volume emergency departments routinely generate hundreds of CT pulmonary angiography (CTPA) studies, making rapid identification of critical findings increasingly challenging.

Artificial intelligence (AI) is reshaping this landscape by serving as an intelligent assistant that improves workflow efficiency, prioritizes urgent examinations, reduces perceptual errors, and supports more consistent interpretation.

Rather than replacing radiologists, AI augments human expertise by integrating image recognition, clinical metadata, quantitative measurements, and workflow automation into a unified diagnostic ecosystem.


Why Pulmonary Embolism Is an Ideal Disease for AI

Among thoracic emergencies, pulmonary embolism possesses several characteristics that make it particularly suitable for AI-assisted diagnosis.

Standardized Imaging Protocols

Most CTPA examinations are performed using highly standardized acquisition parameters, producing consistent image quality across institutions. This consistency enables deep learning algorithms to generalize effectively across diverse patient populations.


Clearly Defined Imaging Targets

Pulmonary emboli appear as intraluminal filling defects within contrast-opacified pulmonary arteries.

Unlike diffuse interstitial lung diseases, emboli possess relatively well-defined anatomical boundaries that facilitate automated detection.


Large Annotated Training Datasets

Thousands of manually labeled CTPA examinations are available for supervised learning.

Radiologist-confirmed emboli provide reliable ground truth annotations that significantly improve algorithm performance.


Time-Critical Clinical Importance

Pulmonary embolism is a true emergency.

Every minute of diagnostic delay increases the risk of:

  • right ventricular failure
  • circulatory collapse
  • cardiac arrest
  • mortality

Therefore, AI systems that shorten reporting time directly improve clinical outcomes.


Deep Learning for Pulmonary Embolism Detection

Modern PE detection algorithms primarily employ convolutional neural networks (CNNs) and transformer-based architectures.

The workflow typically consists of several sequential stages.


Step 1. Image Acquisition

CT Pulmonary Angiography-->Thin-slice reconstruction-->DICOM transmission-->AI server


Step 2. Pulmonary Artery Segmentation

The algorithm automatically identifies:

  • main pulmonary artery
  • right pulmonary artery
  • left pulmonary artery
  • lobar branches
  • segmental arteries
  • subsegmental vessels

Precise vascular segmentation significantly reduces false-positive detections.


Step 3. Embolus Detection

Computer vision models analyze each pulmonary artery voxel to identify:

  • contrast interruption
  • filling defects
  • vessel enlargement
  • abrupt vascular cutoff
  • partial occlusion
  • complete occlusion

Each suspected lesion receives a probability score.


Step 4. Quantitative Analysis

AI automatically calculates:

  • clot volume
  • clot burden
  • obstruction index
  • embolus location
  • vessel diameter
  • RV/LV ratio

These measurements provide objective information beyond simple visual interpretation.


Step 5. Worklist Prioritization

Positive examinations are automatically moved to the top of the radiologist's reading queue.

Emergency physicians receive earlier reports.

Treatment begins sooner.


AI-Assisted Workflow


This workflow significantly reduces turnaround time while preserving physician oversight.


Computer Vision in Chest CT

Computer vision forms the foundation of contemporary PE detection.

Instead of merely identifying a filling defect, advanced algorithms recognize multiple imaging features simultaneously.

Examples include:

Vessel Morphology

  • arterial diameter
  • tapering
  • branching pattern

Contrast Enhancement

  • attenuation measurements
  • enhancement gradients
  • contrast timing

Thrombus Characteristics

  • location
  • length
  • attenuation
  • occlusive percentage

Secondary Findings

Computer vision also evaluates:

  • pulmonary infarction
  • pleural effusion
  • atelectasis
  • right ventricular enlargement
  • interventricular septal deviation

Consequently, AI generates a far more comprehensive assessment than simple embolus detection alone.


Foundation Models

Radiology is entering the era of multimodal foundation models.

Unlike traditional CNNs, foundation models simultaneously process:

Such integrated reasoning represents a major advance over image-only AI systems.


Generative AI in Radiology

Generative AI extends beyond lesion detection by assisting radiologists with communication and documentation.

Applications include:

Automated Report Drafting

The AI produces a preliminary structured report based on imaging findings.

Radiologists verify and edit the report before finalization.


Natural Language Summaries

Reports can be rewritten for:

  • emergency physicians
  • pulmonologists
  • cardiologists
  • patients

Each audience receives language tailored to its level of expertise.


Clinical Recommendations

Generative AI may suggest:

  • lower-extremity venous ultrasound
  • echocardiography
  • anticoagulation consultation
  • thrombectomy evaluation
  • follow-up imaging

Importantly, these recommendations remain advisory and require physician confirmation.


Clinical Decision Support Systems (CDSS)

Modern CDSS integrates imaging with clinical probability models.

For example:


This integration minimizes unnecessary imaging while expediting care for high-risk patients.


AI in Enterprise Imaging

Large healthcare networks increasingly deploy enterprise-wide imaging platforms that integrate:

  • Radiology Information Systems (RIS)
  • PACS
  • Vendor Neutral Archives (VNA)
  • AI inference servers
  • Electronic Health Records (EHR)
  • Cloud storage

When AI detects a pulmonary embolism:

  • the examination is flagged automatically,
  • the radiologist receives a high-priority alert,
  • emergency clinicians are notified,
  • the case is tracked through treatment and follow-up.

This closed-loop workflow improves patient safety and reduces communication delays.


Cloud-Based AI Infrastructure

Cloud-native architectures are becoming central to modern radiology.

Benefits include:

  • scalable computing resources,
  • centralized AI model deployment,
  • continuous algorithm updates,
  • multi-hospital collaboration,
  • reduced on-premises hardware costs.

Cloud-based inference also enables smaller hospitals to access advanced AI capabilities without maintaining expensive local GPU infrastructure.


AI Limitations

Despite impressive advances, AI systems remain imperfect.

Potential limitations include:

False Positives: Artifacts from respiratory motion, streak artifacts, or dense contrast may mimic emboli.


False Negatives: Very small subsegmental emboli may escape detection.


Dataset Bias: Algorithms trained primarily on one population may underperform in different demographic or technical settings.


Generalizability: Performance may decline when scanners, reconstruction kernels, or contrast protocols differ substantially from training data.


Clinical Context: AI cannot independently determine whether an embolus is acute, chronic, clinically significant, or incidental without physician interpretation.


Human–AI Collaboration

The future of pulmonary embolism diagnosis is best viewed as a collaborative model:

AI excels at:

  • rapid image screening,
  • quantitative measurements,
  • worklist prioritization,
  • structured reporting,
  • consistency.

Radiologists excel at:

  • integrating clinical context,
  • resolving ambiguous findings,
  • recognizing uncommon diseases,
  • communicating with treating physicians,
  • making final diagnostic decisions.

The combination consistently outperforms either one working alone.


Key AI Pearls

  1. AI significantly shortens the time to pulmonary embolism diagnosis.
  2. Deep learning accurately detects intraluminal filling defects on CTPA.
  3. Computer vision automatically quantifies clot burden and right ventricular strain.
  4. Foundation models integrate imaging with clinical data for more comprehensive risk assessment.
  5. Generative AI streamlines structured reporting and multidisciplinary communication.
  6. Clinical Decision Support Systems combine imaging findings with validated prediction rules.
  7. Enterprise imaging platforms enable automated triage and closed-loop communication.
  8. Cloud-based AI expands access to advanced diagnostic capabilities across healthcare networks.
  9. AI should augment—not replace—radiologist expertise.
  10. Human–AI collaboration represents the future standard of emergency thoracic imaging.

Looking Ahead

The integration of artificial intelligence into pulmonary embolism imaging is shifting radiology from a reactive specialty to a proactive, intelligence-driven discipline. In the near future, multimodal foundation models will not only identify emboli but also synthesize imaging, laboratory values, genomics, wearable-device data, and longitudinal health records to estimate individualized risk, recommend treatment pathways, and predict outcomes in real time.

For emergency radiologists, mastering these technologies will be as important as recognizing classic imaging signs such as the Westermark sign. The future of pulmonary embolism diagnosis will depend on a seamless partnership between expert clinicians and trustworthy AI systems—where rapid image interpretation, standardized reporting, and data-driven decision support converge to deliver faster, safer, and more personalized patient care.


Diagnostic Workflow

Modern Diagnostic Algorithm for Suspected Pulmonary Embolism

Diagnosing pulmonary embolism (PE) is rarely based on imaging alone. Instead, it requires a structured, evidence-based workflow that integrates clinical probability, laboratory testing, imaging findings, and multidisciplinary decision-making. This approach minimizes unnecessary imaging while ensuring that high-risk patients receive prompt, life-saving treatment.

The patient in this case exemplifies this workflow. She presented with acute dyspnea and hypoxemia, had multiple thromboembolic risk factors (estrogen therapy, previous deep vein thrombosis, and a family history of fatal PE), an elevated D-dimer level, and electrocardiographic evidence of right heart strain. Recognition of the Westermark sign on the initial chest radiograph immediately raised suspicion for pulmonary embolism, leading to CT pulmonary angiography (CTPA), which confirmed extensive bilateral pulmonary emboli.


Step 1. Initial Clinical Assessment

Patients with pulmonary embolism often present with nonspecific symptoms, making clinical evaluation the first and most critical step.

Common Presenting Symptoms

  • Sudden onset dyspnea
  • Pleuritic chest pain
  • Tachypnea
  • Tachycardia
  • Hypoxemia
  • Syncope
  • Hemoptysis
  • Unexplained anxiety

None of these symptoms alone is diagnostic. Instead, clinicians estimate the pretest probability of PE before ordering imaging.


Step 2. Clinical Prediction Rules

Wells Score

The Wells Score remains one of the most widely used clinical prediction tools.

Major variables include:

  • Clinical signs of DVT
  • Alternative diagnosis less likely than PE
  • Tachycardia
  • Recent surgery or immobilization
  • Previous DVT/PE
  • Hemoptysis
  • Malignancy

Interpretation

  • Low probability: D-dimer testing is appropriate.
  • Intermediate probability: D-dimer followed by imaging if positive.
  • High probability: Proceed directly to CTPA without delay.

The patient described in this case would be categorized as high clinical probability due to her history of DVT, estrogen use, elevated D-dimer, and acute presentation.


Step 3. Laboratory Evaluation

D-dimer

D-dimer reflects fibrin degradation and is highly sensitive for acute thromboembolism.

Advantages:

  • Excellent negative predictive value
  • Useful in low-risk patients
  • Rapid availability

Limitations:

  • Low specificity
  • Elevated after surgery
  • Elevated during pregnancy
  • Elevated with malignancy
  • Elevated during infection

Therefore, D-dimer should never be interpreted independently of clinical probability.


Step 4. Initial Imaging

Chest Radiography

Although frequently normal in pulmonary embolism, chest radiography remains valuable because it:

  • excludes pneumothorax
  • excludes pneumonia
  • detects pleural effusion
  • suggests pulmonary infarction
  • occasionally demonstrates classic PE signs

These include:

  • Westermark sign
  • Hampton hump
  • Fleischner sign

The Westermark sign identified in this patient served as the pivotal imaging clue that accelerated definitive diagnosis.


Step 5. Definitive Imaging

CT Pulmonary Angiography (CTPA)

CTPA is the reference standard for diagnosing acute pulmonary embolism.

Radiologists should evaluate:

  • Main pulmonary arteries
  • Lobar arteries
  • Segmental branches
  • Subsegmental branches
  • Right ventricular size
  • Pulmonary infarction
  • Pleural abnormalities
  • Alternative thoracic pathology

In this patient, CTPA demonstrated:

  • Occlusive thrombus within the right pulmonary artery
  • Additional thrombi involving the right upper and middle lobe arteries
  • Multiple emboli in branches of the left pulmonary artery

These findings confirmed bilateral acute pulmonary embolism.


Differential Diagnosis

Accurate diagnosis requires distinguishing pulmonary embolism from several conditions that may present with similar symptoms or imaging findings.

1. Acute Myocardial Infarction

Shared Features:

  • Chest pain
  • Dyspnea
  • Elevated cardiac biomarkers

Distinguishing Features:

  • Coronary artery occlusion
  • Regional myocardial ischemia
  • Typical ECG changes

2. Pneumonia

Shared Features:

  • Dyspnea
  • Fever
  • Chest discomfort

Imaging Differences:

  • Air-space consolidation
  • Air bronchograms
  • No pulmonary arterial filling defect

3. Pneumothorax

Shared Features:

  • Sudden chest pain
  • Dyspnea

Imaging Differences:

  • Visible pleural line
  • Absent peripheral lung markings
  • No intravascular thrombus

4. Acute Heart Failure

Shared Features:

  • Hypoxemia
  • Dyspnea
  • Tachypnea

Imaging Differences:

  • Cardiomegaly
  • Pulmonary edema
  • Pleural effusions

5. Aortic Dissection

Shared Features:

  • Sudden chest pain
  • Hemodynamic instability

CT Findings:

  • Intimal flap
  • False lumen
  • No pulmonary arterial embolus

Structured Radiology Reporting

High-quality structured reporting improves communication with emergency physicians and facilitates AI integration.

Example Structured Report

Examination

CT Pulmonary Angiography with intravenous contrast.


Findings

  • Acute intraluminal filling defect within the right main pulmonary artery.
  • Occlusive thrombi involving the right upper and middle lobar pulmonary arteries.
  • Multiple emboli within segmental branches of the left pulmonary artery.
  • No evidence of saddle embolism.
  • No pleural effusion.
  • No focal pulmonary consolidation.
  • Assess right ventricular size and RV/LV ratio if measurable.

Impression

  1. Acute bilateral pulmonary embolism with predominant right-sided clot burden.
  2. Findings correspond to the oligemic region identified as the Westermark sign on chest radiography.
  3. Recommend immediate clinical correlation and anticoagulation therapy.
  4. Consider echocardiographic evaluation for right ventricular strain if clinically indicated.

AI-Enhanced Diagnostic Workflow


This workflow illustrates how AI complements, rather than replaces, expert radiologic interpretation.


Key Imaging Pearls

Every radiologist should remember the following practical points:

  1. Never dismiss a normal or nearly normal chest radiograph in a patient with high clinical suspicion for PE.
  2. The Westermark sign is uncommon but highly suggestive when identified correctly.
  3. Regional hyperlucency reflects pulmonary oligemia, not hyperinflation.
  4. CTPA remains the imaging gold standard for acute PE.
  5. Evaluate both clot burden and right ventricular strain; prognosis depends on more than thrombus size.
  6. Compare imaging findings with clinical probability and laboratory data—multimodal assessment is essential.
  7. Structured reporting improves clarity, reduces omissions, and supports AI-assisted workflows.
  8. AI can accelerate triage and clot quantification but requires expert oversight.
  9. Always inspect the entire thorax for alternative or concurrent diagnoses, including pneumonia, pneumothorax, or aortic pathology.
  10. Early recognition and rapid anticoagulation remain the most effective strategies for reducing PE-related mortality.
  11. Recognize indirect radiographic signs—such as the Westermark sign—as potential life-saving clues.
  12. Consistent communication between radiologists, emergency physicians, and cardiopulmonary specialists is critical for optimal patient outcomes.

Clinical Lessons from This Case

This case demonstrates that a single subtle abnormality on a routine chest radiograph can profoundly alter patient management. Recognition of the Westermark sign prompted urgent CT pulmonary angiography, which confirmed extensive bilateral pulmonary embolism and led to timely anticoagulation therapy with subsequent clinical recovery.

In today's era of artificial intelligence and high-resolution multidetector CT, classic radiographic signs remain highly relevant. The most effective emergency radiologists are those who combine traditional pattern recognition with advanced imaging technologies, structured reporting, and AI-assisted decision support to deliver rapid, accurate, and patient-centered care.

 

The Future of Pulmonary Embolism Imaging

Pulmonary embolism (PE) imaging is entering a transformative era. While multidetector CT pulmonary angiography (CTPA) remains the diagnostic cornerstone today, the next decade will be defined by artificial intelligence, multimodal foundation models, cloud-native imaging ecosystems, digital twins, and precision medicine. Radiologists will increasingly transition from image interpreters to clinical information integrators, orchestrating data from imaging, laboratory tests, genomics, wearable devices, and electronic health records to support personalized patient care.

For life-threatening conditions such as PE, where every minute influences survival, these innovations promise not only faster diagnosis but also earlier risk prediction, automated triage, and individualized treatment recommendations.


From Image Interpretation to Clinical Intelligence

Historically, radiology has focused on identifying structural abnormalities. The future, however, lies in clinical intelligence, where imaging findings become one component of a larger predictive ecosystem.

For example, a future PE platform may automatically integrate:

  • CT pulmonary angiography findings
  • Chest radiography (e.g., Westermark sign)
  • Electrocardiography
  • D-dimer concentration
  • Cardiac biomarkers
  • Echocardiographic right ventricular function
  • Lower-extremity venous ultrasound
  • Genetic thrombophilia profiles
  • Medication history (e.g., estrogen therapy)
  • Wearable-device cardiopulmonary data

This multimodal synthesis will generate real-time estimates of mortality risk, recurrence probability, bleeding risk during anticoagulation, and recommendations for catheter-directed intervention or intensive care admission.


Foundation Models: Beyond Image Recognition

The emergence of foundation models marks one of the most significant shifts in medical AI. Unlike traditional deep learning systems trained for a single task, foundation models are pretrained on enormous multimodal datasets and adapted to diverse clinical applications.

In pulmonary embolism imaging, future foundation models will:

  • interpret chest X-rays and CTPA simultaneously,
  • correlate imaging with laboratory and clinical data,
  • retrieve relevant prior imaging automatically,
  • summarize patient history,
  • generate structured radiology reports,
  • recommend guideline-based management pathways.

For the current case, such a model would recognize the Westermark sign, identify bilateral pulmonary arterial filling defects, incorporate the patient's history of deep vein thrombosis and estrogen therapy, and classify the case as high-risk acute pulmonary embolism requiring immediate anticoagulation.


Generative AI and Autonomous Reporting

Generative AI is expected to become an integral component of radiology reporting.

Future Workflow


Instead of dictating reports from scratch, radiologists will increasingly supervise AI-generated drafts, improving consistency while reducing reporting time. Importantly, the radiologist will remain responsible for validating findings, resolving ambiguities, and integrating clinical context.


Predictive Analytics and Personalized Medicine

Future PE management will extend beyond diagnosis to prediction.

AI systems will estimate:

  • likelihood of hemodynamic collapse,
  • probability of recurrent thromboembolism,
  • anticipated response to anticoagulation,
  • bleeding risk,
  • long-term development of chronic thromboembolic pulmonary hypertension.

These predictions will enable clinicians to tailor treatment intensity to the individual patient rather than relying solely on population-based guidelines.


Digital Twins in Cardiopulmonary Imaging

An emerging concept in precision medicine is the digital twin—a virtual representation of an individual patient continuously updated with clinical, imaging, and physiological data.

In pulmonary embolism, a digital twin could simulate:

  • pulmonary blood flow,
  • right ventricular function,
  • response to thrombolytic therapy,
  • effects of catheter-directed thrombectomy,
  • long-term vascular remodeling.

Although still largely investigational, digital twins may become valuable tools for treatment planning in complex cardiovascular disease.


Enterprise AI Platforms

Large healthcare systems are rapidly adopting enterprise-wide AI platforms that integrate imaging, analytics, and workflow management across multiple hospitals.

These platforms support:

  • automated case prioritization,
  • standardized structured reporting,
  • longitudinal patient tracking,
  • quality assurance,
  • performance benchmarking,
  • multidisciplinary communication.

For pulmonary embolism, an enterprise AI platform can automatically flag positive CTPA examinations, notify emergency physicians, and document treatment milestones, reducing delays and improving patient safety.


PACS Evolution: From Archive to Intelligent Platform

Picture Archiving and Communication Systems (PACS) are evolving from passive image repositories into intelligent clinical workspaces.

Future PACS environments will include:

  • embedded AI inference engines,
  • automated measurement tools,
  • real-time decision support,
  • natural language search,
  • multimodal data integration,
  • interactive reporting dashboards.

Rather than launching separate software, radiologists will access AI-generated insights directly within the PACS interface, streamlining workflow and reducing cognitive load.


Cloud Healthcare Infrastructure

Cloud-native infrastructure will play a central role in the next generation of medical imaging.

Advantages include:

  • scalable computational resources,
  • centralized AI deployment,
  • rapid software updates,
  • secure image sharing,
  • collaborative interpretation across institutions,
  • disaster recovery,
  • Reduced hardware maintenance costs.

For smaller hospitals, cloud-based AI services will provide access to advanced diagnostic capabilities without the need for local high-performance computing infrastructure.


AI Diagnostic Software Market

The market for AI diagnostic software is expanding rapidly, particularly in emergency imaging.

Key application areas include:

  • Pulmonary embolism detection
  • Stroke triage
  • Intracranial hemorrhage detection
  • Lung nodule analysis
  • Coronary artery calcium scoring
  • Breast cancer screening
  • Musculoskeletal fracture detection

Healthcare organizations are increasingly investing in AI platforms that demonstrate measurable improvements in workflow efficiency, diagnostic accuracy, and patient outcomes.


Ethical and Regulatory Considerations

As AI becomes more deeply integrated into clinical practice, ethical governance is essential.

Future regulatory priorities include:

  • algorithm transparency,
  • external validation,
  • bias mitigation,
  • continuous post-market surveillance,
  • cybersecurity,
  • human oversight,
  • explainable AI,
  • data privacy.

Maintaining patient trust requires that AI recommendations remain interpretable and that final clinical responsibility continues to reside with qualified healthcare professionals.


High-Value Healthcare Technology Topics

The convergence of radiology and digital health is driving innovation in several commercially significant domains:

  • Enterprise AI Platforms
  • Clinical Decision Support Systems
  • Intelligent PACS Solutions
  • Vendor Neutral Archives (VNA)
  • Cloud Healthcare Infrastructure
  • AI Diagnostic Software
  • Workflow Automation
  • Precision Medicine
  • Digital Pathology Integration
  • Federated Learning
  • Imaging Analytics
  • Population Health Management

These technologies are increasingly relevant to healthcare executives, imaging scientists, and enterprise decision-makers seeking scalable solutions for modern radiology departments.


Final Conclusion

Pulmonary embolism remains one of the most time-sensitive diagnoses in emergency medicine, demanding rapid recognition and coordinated multidisciplinary care. This case illustrates how a subtle but classic radiographic finding—the Westermark sign—can trigger timely CT pulmonary angiography, confirm extensive bilateral pulmonary embolism, and ultimately lead to successful treatment.

While chest radiography continues to provide valuable diagnostic clues, the future of PE imaging extends far beyond conventional interpretation. Artificial intelligence, multimodal foundation models, enterprise imaging platforms, cloud-native infrastructure, and predictive analytics are redefining how radiologists detect disease, communicate findings, and support clinical decision-making.

The radiologist of the future will not be replaced by AI but empowered by it—combining human expertise with intelligent technologies to deliver faster diagnoses, more consistent reporting, and truly personalized patient care. In this evolving landscape, mastering both classic imaging signs and emerging digital tools will be essential for improving outcomes in one of medicine's most critical emergencies.


Key Takeaways

Clinical

  • Pulmonary embolism remains one of the leading causes of preventable in-hospital mortality.
  • Early diagnosis significantly reduces mortality.
  • Chest radiography is often normal, but recognition of the Westermark sign can provide a critical early clue.
  • CT pulmonary angiography remains the reference standard for diagnosis.
  • Right ventricular strain assessment is essential for risk stratification.

Imaging

  • Westermark sign represents focal pulmonary oligemia.
  • CTPA directly demonstrates pulmonary arterial filling defects.
  • Bilateral emboli may produce asymmetric chest radiographic findings.
  • Structured reporting improves communication and consistency.
  • AI-assisted clot quantification enhances workflow efficiency.

Artificial Intelligence

  • Deep learning accelerates pulmonary embolism detection.
  • Foundation models integrate imaging with clinical information.
  • Generative AI streamlines structured reporting.
  • Enterprise imaging platforms improve multidisciplinary communication.
  • Human oversight remains indispensable.

Future

  • Precision medicine will individualize PE treatment.
  • Cloud-native imaging ecosystems will expand access to advanced AI.
  • Predictive analytics will identify patients at greatest risk.
  • Digital twins may support personalized simulation of treatment.
  • Radiologists will increasingly function as clinical information specialists.

References

  1. Konstantinides SV, et al. 2024 ESC Guidelines for the diagnosis and management of acute pulmonary embolism. European Heart Journal. DOI: 10.1093/eurheartj/ehae528
  2. Stein PD, et al. Multidetector computed tomography for acute pulmonary embolism. New England Journal of Medicine. DOI: 10.1056/NEJMoa052367
  3. Schoepf UJ, et al. CT angiography for diagnosis of pulmonary embolism. Radiology. DOI: 10.1148/radiol.2362041237
  4. Wittram C, et al. CT angiography of pulmonary embolism. AJR American Journal of Roentgenology. DOI: 10.2214/AJR.176.6.1761387
  5. Kearon C, et al. Antithrombotic therapy for venous thromboembolism disease. Chest. DOI: 10.1016/j.chest.2015.11.026
  6. Raja AS, et al. Evaluation of patients with suspected pulmonary embolism. Annals of Internal Medicine. DOI: 10.7326/M14-1772
  7. Huang SC, et al. Foundation models in medical imaging. Nature Reviews Bioengineering. DOI: 10.1038/s44222-023-00050-2
  8. Esteva A, et al. A guide to deep learning in healthcare. Nature Medicine. DOI: 10.1038/s41591-019-0548-6
  9. Topol EJ. High-performance medicine: the convergence of human and artificial intelligence. Nature Medicine. DOI: 10.1038/s41591-019-0449-0
  10. Rajpurkar P, et al. AI in radiology: opportunities and challenges. Radiology. DOI: 10.1148/radiol.2020201908
  11. Hosny A, et al. Artificial intelligence in radiology. Nature Reviews Cancer. DOI: 10.1038/nrc.2018.89
  12. Erickson BJ, et al. Machine learning for medical imaging. Radiographics. DOI: 10.1148/rg.2019180155
  13. Lundervold AS, et al. An overview of deep learning in medical imaging. Zeitschrift für Medizinische Physik. DOI: 10.1016/j.zemedi.2018.11.002
  14. Pesapane F, et al. Artificial intelligence as a medical device. European Radiology. DOI: 10.1007/s00330-018-5762-1
  15. Thrall JH, et al. Artificial intelligence and machine learning in radiology. Radiology. DOI: 10.1148/radiol.2017162700

Comments

Popular posts from this blog

Understanding Tubal Ligation Clips: Imaging, Risks, Migration, and Management

Teres Minor Atrophy: Causes, Imaging, and Clinical Implications

The Lethal Lens: Mastering the Diagnosis and Management of Epidural Hemorrhage (EDH)